Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL).
Giuseppe Longo(University of Modena and Reggio Emilia), Vittorio Silingardi(University of Modena and Reggio Emilia), Massimo Federico(University of Modena and Reggio Emilia), Marco Lombardo(Vision Engineering (Italy)), Fiorella Ilariucci(Azienda Sanitaria Unità Locale di Reggio Emilia), Daniele Vallisa(Ospedaliera di Piacenza), F. Angrilli(University of Padua), Stefano Sacchi(University of Modena and Reggio Emilia), Claudia Fiorani(University of Modena and Reggio Emilia), Antonio Frassoldati(Italian Oncology Group of Clinical Research), Mario Petrini, Paolo G. Gobbi(University of Pavia), Caterina Stelitano(University of Reggio Calabria), Vincenzo Callea(Azienda Ospedaliero Universitaria San Giovanni Battista)
PubMed
May 1, 1999
Cited by 11
Related Papers
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553